Based on 9 analysts giving stock ratings to Sana Biotechnology Inc in the past month.
In the current month, SANA has received 4 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. SANA average Analyst price target in the last month is 8.500.
Based on analysts' estimates, SANA EPS is projected to reach -0.180 in FY2026Q4, following reported EPS of 0.066 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD 0.07, while Sana Biotechnology IncSANA's earnings per share (EPS) for the previous quarter was USD -0.22. EPS for the next quarter is expected at USD -0.18.